- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/00 - Drugs for disorders of the nervous system
Patent holdings for IPC class A61P 25/00
Total number of patents in this class: 18469
10-year publication summary
|
445
|
497
|
760
|
940
|
991
|
1070
|
1183
|
1299
|
1242
|
914
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7944 |
275 |
| The Regents of the University of California | 20211 |
190 |
| Janssen Pharmaceutica N.V. | 3352 |
177 |
| Takeda Pharmaceutical Company Limited | 2713 |
175 |
| Hoffmann-La Roche Inc. | 3511 |
139 |
| Glaxo Group Limited | 4138 |
96 |
| H. Lundbeck A/S | 1245 |
95 |
| Centre National de La Recherche Scientifique | 10641 |
93 |
| Novartis AG | 10674 |
90 |
| Sage Therapeutics, Inc. | 375 |
89 |
| The Johns Hopkins University | 5737 |
85 |
| Daiichi Sankyo Company, Limited | 1881 |
82 |
| Pfizer Inc. | 3388 |
78 |
| Neurosearch A/S | 175 |
78 |
| sanofi-aventis | 352 |
77 |
| AstraZeneca AB | 2853 |
74 |
| Boehringer Ingelheim International GmbH | 4649 |
73 |
| Osaka University | 3394 |
71 |
| Bristol-myers Squibb Company | 4847 |
62 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3370 |
58 |
| Other owners | 16312 |